{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:34:04Z","timestamp":1779118444030,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019531","name":"Science Fund for Distinguished Young Scholars of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-JQX0021"],"award-info":[{"award-number":["CSTB2023NSCQ-JQX0021"]}],"id":[{"id":"10.13039\/501100019531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["202413020649"],"award-info":[{"award-number":["202413020649"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114320","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:56:36Z","timestamp":1760662596000},"page":"114320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Intrahepatic targeting and sustained release of a Toll like receptor 8 agonist enhances hepatocellular carcinoma therapy"],"prefix":"10.1016","volume":"388","author":[{"given":"Zhongjie","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongcheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binhua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranran","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxing","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114320_bb0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114320_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114320_bb0015","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0020","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114320_bb0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1053\/j.gastro.2021.12.276","article-title":"AGA clinical practice guideline on systemic therapy for hepatocellular carcinoma","volume":"162","author":"Su","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.114320_bb0030","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.7150\/thno.54822","article-title":"Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma","volume":"11","author":"Kong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114320_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156774","article-title":"HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy","volume":"132","author":"Salman","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114320_bb0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-024-45167-5","article-title":"Activation of GPR3-\u03b2-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis","volume":"15","author":"Dong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114320_bb0045","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/gutjnl-2021-324170","article-title":"MicroRNA-206 promotes the recruitment of CD8(+) T cells by driving M1 polarisation of Kupffer cells","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.114320_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202306483","article-title":"GO-PEG represses the progression of liver inflammation via regulating the M1\/M2 polarization of Kupffer cells","volume":"20","author":"Ding","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114320_bb0055","article-title":"Targeted xCT-mediated Ferroptosis and Protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114320_bb0060","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41586-023-06950-4","article-title":"The nuclear factor ID3 endows macrophages with a potent anti-tumour activity","volume":"626","author":"Deng","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114320_bb0065","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/s41467-023-41438-9","article-title":"Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8(+) T cells to boost anti-PD-1 therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114320_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122708","article-title":"Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy","volume":"311","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114320_bb0075","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.7150\/thno.47137","article-title":"USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114320_bb0080","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-024-50568-7","article-title":"Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114320_bb0085","first-page":"455","article-title":"Effect of Kupffer cells depletion on ABC phenomenon induced by Kupffer cells-targeted liposomes, Asian","volume":"14","author":"Lai","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114320_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119457","article-title":"Liver-targeted Nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance","volume":"222","author":"Wu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114320_bb0095","article-title":"Nanoparticle drug delivery can reduce the hepatotoxicity of therapeutic cargo","volume":"16","author":"Yang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114320_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102482","article-title":"The path ahead for understanding toll-like receptor-driven systemic autoimmunity","volume":"91","author":"Hamerman","year":"2024","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0105","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1021\/acs.jmedchem.4c03148","article-title":"Discovery of novel Isoxazole-based small-molecule toll-like receptor 8 antagonists","volume":"68","author":"Matziol","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114320_bb0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-024-07614-7","article-title":"Molecular definition of the endogenous toll-like receptor signalling pathways","volume":"631","author":"Fisch","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114320_bb0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114320_bb0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2019.05.002","article-title":"Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases","volume":"64","author":"Patra","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114320_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.03.001","article-title":"Harnessing the immune system to fight cancer with toll-like receptor and RIG-I-like receptor agonists","volume":"154","author":"Bourquin","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2025.114320_bb0140","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114320_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4049\/immunohorizons.2000002","article-title":"TLR7 and TLR8 differentially activate the IRF and NF-\u03baB pathways in specific cell types to promote inflammation","volume":"4","author":"Bender","year":"2020","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.jconrel.2025.114320_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2019.10.020","article-title":"TLR 7\/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages","volume":"469","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114320_bb0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12951-024-02525-1","article-title":"A combination of a TLR7\/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune","volume":"22","author":"Jiang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cmet.2018.09.020","article-title":"TLR8-mediated metabolic control of human Treg function: a mechanistic target for cancer immunotherapy","volume":"29","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2025.114320_bb0165","series-title":"First-in-Human Study of ZG0895, a TLR8 Selective Agonist, as Monotherapy in Patients with Advanced Solid Tumors, in","author":"Sun","year":"2024"},{"key":"10.1016\/j.jconrel.2025.114320_bb0170","series-title":"Imidazoquinoline Substituted Phosphoric Ester Agonist, and Preparation Therefor and Application Thereof","author":"Lv","year":"2023"},{"key":"10.1016\/j.jconrel.2025.114320_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abp8309","article-title":"CD47-SIRP\u03b1 axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis","volume":"14","author":"Shi","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114320_bb0180","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114320_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/eji.200939863","article-title":"Leishmania donovani-induced expression of signal regulatory protein alpha on Kupffer cells enhances hepatic invariant NKT-cell activation","volume":"40","author":"Beattie","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0190","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \u201cself\u201d peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114320_bb0195","doi-asserted-by":"crossref","first-page":"15083","DOI":"10.1021\/acsnano.0c05091","article-title":"Multivalent, soluble Nano-self peptides increase phagocytosis of antibody-opsonized targets while suppressing \u201cself\u201d signaling","volume":"14","author":"Jalil","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114320_bb0200","doi-asserted-by":"crossref","first-page":"18100","DOI":"10.1021\/acsnano.1c06707","article-title":"Precise delivery of nanomedicines to M2 macrophages by combining \u201ceat me\/don\u2019t eat me\u201d signals and its anticancer application","volume":"15","author":"Tang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114320_bb0205","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114320_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202307694","article-title":"Nanoengineered macrophages armed with TLR7\/8 agonist enhance remodeling of immunosuppressive tumor microenvironment","volume":"20","author":"Yoo","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114320_bb0215","first-page":"164","article-title":"Expression of glucose transporters in cancers","volume":"2013","author":"Szablewski","year":"1835","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.114320_bb0220","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1517\/14728220903307509","article-title":"GLUT1 as a therapeutic target in hepatocellular carcinoma","volume":"13","author":"Amann","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2025.114320_bb0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-00390-6","article-title":"Identification and construction of a novel biomimetic delivery system of paclitaxel and its targeting therapy for cancer","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114320_bb0230","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41467-022-29780-w","article-title":"Boron encapsulated in a liposome can be used for combinational neutron capture therapy","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114320_bb0235","article-title":"Irinotecan-loaded ROS-responsive liposomes containing thioether phosphatidylcholine for improving anticancer activity","volume":"71","author":"Zhang","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0240","doi-asserted-by":"crossref","first-page":"26269","DOI":"10.1038\/srep26269","article-title":"Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes","volume":"6","author":"Qie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114320_bb0245","first-page":"50966","article-title":"Bone marrow-derived macrophage production","volume":"JoVE","author":"Trouplin","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2025.114320_bb0250","doi-asserted-by":"crossref","first-page":"12875","DOI":"10.1021\/bi980096y","article-title":"Liposome\u2212 cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes","volume":"37","author":"Miller","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2025.114320_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114320_bb0260","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1016\/j.biomaterials.2010.02.068","article-title":"Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer","volume":"31","author":"Maeng","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114320_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.02.019","article-title":"Size-and pathotropism-driven targeting and washout-resistant effects of boronic acid-rich protein nanoparticles for liver cancer regression","volume":"168","author":"Wang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114320_bb0270","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1021\/acsnano.9b05679","article-title":"Overcoming the reticuloendothelial system barrier to drug delivery with a \u201cdon\u2019t-eat-us\u201d strategy","volume":"13","author":"Tang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114320_bb0275","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.2147\/IJN.S333279","article-title":"Platelet-tumor cell hybrid membrane-camouflaged nanoparticles for enhancing therapy efficacy in glioma","author":"Wu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.114320_bb0280","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood-2003-01-0283","article-title":"Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity","volume":"102","author":"Vogel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.114320_bb0285","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0290","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114320_bb0295","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.7150\/thno.95766","article-title":"Hypoxia-driven M2-polarized macrophages facilitate the epithelial-mesenchymal transition of glioblastoma via extracellular vesicles","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114320_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","article-title":"Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression","volume":"44","author":"Ye","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114320_bb0305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114320_bb0310","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114320_bb0315","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12951-024-02727-7","article-title":"Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113521","article-title":"C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophages to facilitate metastatic potential after radiation","volume":"198","author":"Chiang","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114320_bb0325","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0330","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.imlet.2012.08.008","article-title":"MyD88-dependent interleukin-10 production from regulatory CD11b+Gr-1(high) cells suppresses development of acute cerulein pancreatitis in mice","volume":"148","author":"Koike","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2025.114320_bb0335","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Sousa","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114320_bb0340","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1038\/s41467-024-49059-6","article-title":"Glycolysis inhibition induces anti-tumor central memory CD8(+)T cell differentiation upon combination with microwave ablation therapy","volume":"15","author":"Tang","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:06:14Z","timestamp":1769868374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":68,"alternative-id":["S0168365925009344"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114320","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrahepatic targeting and sustained release of a Toll like receptor 8 agonist enhances hepatocellular carcinoma therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114320"}}